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E-mail address: david.leitsch@meduniwien.ac.at (DGiardia lamblia (syn. duodenalis, intestinalis) is a globally occurring micro-aerophilic human parasite that
causes gastrointestinal disease. Standard treatment of G. lamblia infections is based on the 5-nitroimidaz-
ole drugs metronidazole and tinidazole. In two other micro-aerophilic parasites, Entamoeba histolytica
and Trichomonas vaginalis, 5-nitroimidazole drugs bind to proteins involved in the thioredoxin-mediated
redox network and disrupt the redox equilibrium by inhibiting thioredoxin reductase and depleting
intracellular thiol pools. The major aim of this study was to assess whether nitroimidazoles exert a sim-
ilar toxic effect on G. lamblia physiology.
The 5-nitroimidazoles metronidazole and tinidazole were found to bind to the same subset of proteins
including thioredoxin reductase. However, in contrast to E. histolytica and T. vaginalis, none of the other
proteins bound are candidates for being involved in the thioredoxin-mediated redox network. Translation
elongation factor EF-1c, an essential factor in protein synthesis, was widely degraded upon treatment
with 5-nitroimidazoles. 2-Nitroimidazole (azomycin) and the 5-nitroimidazole ronidazole did not bind
to any G. lamblia proteins, which is in contrast to previous ﬁndings in E. histolytica and T. vaginalis. All
nitroimidazoles tested reduced intracellular thiol pools in G. lamblia, but metronidazole, also in contrast
to the situation in the other two parasites, had the slightest effect. Taken together, our results suggest
that nitroimidazole drugs affect G. lamblia in a fundamentally different way than E. histolytica and T.
vaginalis.
 2012 Australian Society for Parasitology Published by Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Giardia lamblia (syn. duodenalis, intestinalis) is considered to be
the most common protozoan intestinal parasite worldwide (Buret,
2008). It causes giardiasis, a disease with symptoms such as diar-
rhea, nausea and failure to thrive in infected children. Treatment
of giardiasis is mainly based on metronidazole (Tejman-Yarden
and Eckman, 2011), a 5-nitroimidazole drug which is exclusively
toxic to microaerophilic and anaerobic microorganisms (Samuel-
son, 1999). Alternatively, another 5-nitroimidazole drug, tinida-
zole, is often prescribed (Fung and Doan, 2005).
The selective toxicity of 5-nitroimidazoles to microaerophiles
and anaerobes has been ascribed to the existence of factors in these
organisms that can transfer electrons to the nitro group and, there-
fore, activate the prodrug metronidazole to its active state (Müller,Published by Elsevier Ltd.
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Open ac1983). Further, since the single electron transfer product, the nitro-
radical anion, is easily re-oxidized by oxygen to the parent com-
pound (Pervez-Reyes et al., 1980) effective doses of activated
drug are only achieved in organisms with very low intracellular
oxygen concentrations. It is still not fully understood whether
the nitroradical anion state or a further reduced state, e.g. the nitr-
osoimidazole state, is the actual agent (Moreno and Docampo,
1985). There is certain evidence that the latter could be the case
(West et al., 1982; Wislocki et al., 1984). In G. lamblia, several fac-
tors have been suggested to reduce 5-nitroimidazoles, including
ferredoxin, which in turn receives electrons from pyruvate:ferre-
doxin oxidoreductase (Townson et al., 1996), nitroreductase 1 (Nil-
lius et al., 2011), and thioredoxin reductase (Leitsch et al., 2011).
Comparably little is known about the mode of action of 5-nitro-
imidazoles in G. lamblia. In general, these drugs are considered to
damage DNA (Edwards, 1993) but it has as yet not been conclu-
sively demonstrated that this damage is caused by direct attack
of 5-nitroimiazoles on DNA rather than by secondary events (LaR-
usso et al., 1978). Indeed, it was recently suggested that metroni-
dazole induces programmed cell death in G. lamblia which also
includes fragmentation of DNA (Ghosh et al., 2009; Bagchi et al.,cess under CC BY-NC-ND license.
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sal surface and the lateral ﬂange upon treatment with metronida-
zole (Campanati and Monteiro-Real, 2002; Müller et al., 2006). Also
damage to the ventral disk was observed (Oxberry et al., 1994) but
this effect was not conﬁrmed in other studies (Campanati and
Monteiro-Real, 2002; Müller et al., 2006).
In our previous work on metronidazole action in Entamoeba his-
tolytica (Leitsch et al., 2007) and Trichomonas vaginalis (Leitsch
et al., 2009) we performed proteomic analyses with nitroimidaz-
ole-treated parasites and showed that metronidazole forms cova-
lent adducts with a deﬁned subset of proteins, including
thioredoxin reductase and proteins that are known or likely to de-
pend on thioredoxin-mediated reduction. Thioredoxin reductase
activity was strongly diminished after nitroimidazole treatment,
resulting in impaired removal of hydrogen peroxide by peroxidases
(Leitsch et al., 2009). Furthermore, nitroimidazoles were shown to
deplete intracellular thiol pools (Leitsch et al., 2007, 2009). Taken
together, our results suggested that nitroimidazoles disrupt the re-
dox system in these parasites.
In order to shed more light on metronidazole action in G. lamb-
lia and to ﬁnd further evidence for our claim that nitroimidazoles
strike at the cellular redox system in microaerophilic parasites,
we performed an analogous study in G. lamblia using a variety of
nitroimidazole drugs, including metronidazole, tinidazole, ronidaz-
ole and 2-nitroimidazole (azomycin).OH S OO








Fig. 1. The nitroimidazoles used in this study: (1) Metronidazole; (2) tinidazole; (3)
ronidazole; (4) 2-nitroimidazole (azomycin).2. Materials and methods
2.1. Nitroimidazoles
Metronidazole, ronidazole, tinidazole, and 2-nitroimidazole
(azomycin) were purchased from Sigma–Aldrich.
2.2. Cell culture
G. lamblia BRIS/83/HEPU/106 (referred to as 106) was grown in
completely ﬁlled and tightly closed 25 ml polysterene culture
ﬂasks (Falcon, Becton–Dickinson) in modiﬁed TYI-S-33 medium
containing bovine bile (Keister, 1983).
2.3. Analysis by two-dimensional gel electrophoresis (2DE)
G. lamblia cultures (2–5  107 cells) were harvested at RT by
centrifugation at 750g (5 min). Cell pellets were subsequently
washed in two centrifugation steps (750g at RT, 5 min) in 1
PBS. Cells were resuspended in 2 ml of 10% trichloroacetic acid,
20% ultrapure water and 70% acetone, and incubated at 20 C
for at least 1 h. Afterwards, the samples were centrifuged at
20,000g at 4 C and washed twice by in 90% acetone followed by
centrifugation at 20,000g (at 4 C for 20 min). Samples were resol-
ubilised in an appropriate amount of sample buffer (7 M urea, 2 M
thiourea, 1% dithithreitol, 1% ampholytes pH 3–10) and insoluble
material was removed by centrifugation at 20,000g (at 20 C for
20 min). Two-dimensional gel electrophoresis (2DE) was per-
formed as described (Leitsch et al., 2005). For isoelectric focussing
in 17 cm IPG strips, 500 lg of protein were loaded. The second
dimension was run over 20  20 cm gels in a Protean II xi cell (Bio-
Rad). Gels were Coomassie-stained and images were evaluated
using Melanie™ 4 software (Genebio).
2.4. Identiﬁcation of proteins by mass spectrometric analysis
Protein identiﬁcation was performed as described recently
(Leitsch et al., 2011). Excised protein spots were digested with
0.02 mg/ml trypsin (modiﬁed, sequencing grade, Roche).Subsequently, acidiﬁed peptides were spotted on a Bruker Anchor-
Chip™ target with matrix ((alpha)-cyano-4-hydroxy-cinnamic
acid) 0.5 mg/ml in 90% acetonitrile, 0.1% triﬂuoroacetic acid
(TFA). Samples were washed with 0.5% TFA and re-crystallized in
6:3:1 ethanol:acetone:10 mM ammonium phosphate in 0.1% TFA.
Mass spectrometry (MS) and tandem mass spectrometry (MS/
MS) data were obtained using a Bruker Daltonics Ultraﬂex III, MAL-
DI TOF/TOF mass spectrometer. Mascot software (2.2.02) was used
to search against the NCBInr database with mass tolerances of
0.4 Da for MS and 0.8 Da for MS/MS.
2.5. Measurement of non-protein thiol pools
Cultures were incubated with the concentrations of nitroimi-
dazoles indicated for 2 h or left untreated. After harvest, pellets
were washed once in 1 PBS. Pellets were resuspended in
20 mM EDTA and cells were lysed by addition of 0.1% Triton X-
100. Insoluble material was removed by centrifugation at
20,000g for 10 min. Protein concentrations in the supernatants
were determined by Bradford assay (Bio-Rad). Subsequently, pro-
teins were removed by precipitation in 5% TCA at room tempera-
ture, followed by centrifugation at 20,000g for 5 min. To the
supernatants the double volume each of 0.4 M Tris/HCl pH 8.9
and 1.7 ll 100 mM Ellman’s reagent (DTNB) were added per ml
reaction mixture. Reduction of DTNB was measured at OD412 in a
Perkin Elmer Lambda 25 UV–Vis spectrometer
(De412 = 13.6 mM1 cm1).
3. Results and discussion
3.1. Binding of metronidazole and tinidazole to a small subset of
proteins including thioredoxin reductase
In analogy to our previous work on metronidazole action in E.
histolytica (Leitsch et al., 2007) and T. vaginalis (Leitsch et al.,
2009), two-dimensional gel electrophoresis (2DE) was performed
in order to identify G. lamblia proteins that are bound by metroni-
dazole and other nitroimidazoles (Fig. 1). G. lamblia strain 106
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metronidazole (10 lM, 50 lM), followed by harvest and prepara-
tion of lysates for 2DE. In total, nine protein spots were found to
be shifted to a more basic pI (Fig. 2A) as typically observed with
nitroimidazole-protein adducts (Leitsch et al., 2007, 2009). Shifting
of proteins in terms of pI depended on the concentration of metro-
nidazole applied, the shifted proportions of all proteins bound
being smaller at 10 lM as compared to 50 lM metronidazole
(Fig. 2B). With two protein spots, 6 and 7 (Table 1), clearly-deﬁned
adducts could only be observed if 10 lM metronidazole were ap-
plied (Fig. 2B), whereas treatment with 50 lMmetronidazole obvi-
ously induced degradation of the protein. In order to rule out that
the observed shifts were caused by apoptotic or necrotic processes,
nitroimidazole binding G. lamblia cultures were exposed to other
nitroimidazoles (Fig. 1) which had been shown to have a similar
mode of action as metronidazole in E. histolytica (Leitsch et al.,
2007) and T. vaginalis (Leitsch et al., 2009). As observed before in
E. histolytica and T. vaginalis, tinidazole bound the same proteins
as metronidazole (Fig. 2B) but caused smaller shifts in pI due to
its different charge as compared to metronidazole (Leitsch et al.,
2007). Surprisingly, another 5-nitroimidazole, ronidazole (Fig. 1),
only induced the degradation of EF-1c but did not lead to any dis-
cernible protein shifts (not shown) although it is more toxic to G.
lamblia than any other nitroimidazole used in this study (Boreham
et al., 1985). It is important to note that in E. histolytica ronidazole
readily forms adducts with proteins (unpublished data), ruling out
that the 2DE procedure itself resolves ronidazole adducts with pro-
teins. Equally surprising, treatment with 2-nitroimidazole (azomy-
cin) did not lead to any protein shifts (not shown) although it had
been found to bind to proteins in E. histolytica (Leitsch et al., 2007)
and in T. vaginalis (unpublished data). Nevertheless, 2-nitroimidaz-
ole was strongly toxic to G. lamblia and led to total immotility and
detachment of most of the cells from the bottom of the culture
ﬂasks when being applied at 50 lM for 2 h. Also control samples
treated with the nitrofuran drug furazolidone (50 lM for 2 h)
and the benzimidazole drug albendazole (20 lM for 3 h) did not
display any discernible adduct formation (data not shown), indi-
cating that the protein shifts observed with metronidazole and















Fig. 2. (A) a 2D-gel (20  20 cm, pH 5–8) showing all proteins bound by metronidazole
either treated with 10 lMmetronidazole (Mz), 50 lMmetronidazole, or 50 lM tinidazol
appearing protein spots containing the affected protein shifted to a more basic pI (to the
and 7, the original spots are indicated by continuous circles and shifted portions by bro
narrow that no new distinct spots containing tinidazole-bound protein are discernible. I
following proteins: (1) thioredoxin reductase; (2) alpha-11 giardin; (3) b-giardin; (4) Gi
elongation factor-1c; (8) pyruvate phosphate dikinase; (9) alcohol dehydrogenase. For drather, direct binding of activated metabolites of these drugs to
proteins.
Protein spots were isolated for mass spectrometric identiﬁca-
tion by peptide mass ﬁngerprinting. The nine spots contained eight
different proteins (Table 1), including thioredoxin reductase. How-
ever, with the exception of thioredoxin reductase none of the pro-
teins identiﬁed have been reported to be involved in the
thioredoxin-mediated redox system as is the case in E. histolytica
(Leitsch et al., 2007) and T. vaginalis (Leitsch et al., 2009). Amongst
the proteins bound were two structural proteins (giardins) and a
Giardia trophozoite antigen (GTA-2) with unknown function. Fur-
ther, an alcohol dehydrogenase with a coenzyme A acylating alde-
hyde dehydrogenase (ACDH) domain, pyruvate phosphate dikinase
(PPDK), a branched-chain amino acid transferase, and elongation
factor-1c (EF-1c), which localized to two distinct protein spots,
were identiﬁed. To the best of our knowledge, none of these pro-
teins have ever been suggested to interact with thioredoxin, nei-
ther in G. lamblia, nor in any other organism. It is interesting to
note, however, that co-puriﬁcation experiments suggest that PPDK
is associated with pyruvate:ferredoxin oxidoreductase (PFOR) (An-
ita Burgess, unpublished results), an enzyme known to reduce
nitroimidazoles via ferredoxin (Townson et al., 1996; Leitsch
et al., 2011). In addition, GTA-2 and the herein identiﬁed alcohol
dehydrogenase localize in native polyacrylamide gels together
with PFOR (Anita Burgess, unpublished results). These observa-
tions imply that PPDK, GTA-2, and alcohol dehydrogenase might
be targets of nitroimidazoles because they are closely associated
with PFOR, a source of reactive nitroimidazole metabolites (Town-
son et al., 1996; Leitsch et al., 2011).
Unfortunately, our attempts to identify a thioredoxin which is
reduced by G. lamblia thioredoxin reductase have so far been
unsuccessful (Leitsch et al., 2011). Thus, we could not measure in
the present study whether nitroimidazole treatment has a detri-
mental effect on thioredoxin reductase activity, as previously done
in E. histolytica and T. vaginalis (Leitsch et al., 2007, 2009). A highly
probable drug target of metronidazole and other 5-nitroimidaz-
oles, however, is EF-1c, having an essential function in protein syn-
thesis. Whether nitroimidazole binding to the other identiﬁed








untreated Mz 50 µM Tz 50 µM Mz 10 µM 
and tinidazole. (B) close-up of the affected proteins in untreated cells, and in cells
e (Tz) for 2 h. Covalent adducts of metronidazole and tinidazole are visible as newly
right). Shifted portions of proteins are indicated by arrows. In the case of proteins 6
ken circles. Some of the protein shifts with tinidazole (proteins 5, 8, and 9) are so
nstead, the original spots are extended to a more basic pI. The numbers refer to the
ardia trophozoite antigen 2; (5) branched-chain amino acid transferase; (6) and (7)
etails see Table 1.
Table 1
The eight proteins bound by metronidazole and tinidazole.
Spot Protein MW (Da) Theoret. pI Accession No. Mowse scoreb
1 Thioredoxin reductasea 33,869 6.16 XP_001707168 166
2 Alpha-11 giardin 35,011 5.74 XP_001705101 522
3 b-Giardin 30,877 5.25 XP_001705425 634
4 Giardia trophozoite antigen 2 26,569 6.95 XP_001709922 271
5 Branched-chain amino acid transferase 39,065 6.14 XP_001706262 207
6 + 7 Elongation factor-1c 45,217 6.05 XP_001707321 320
8 Pyruvate phosphate dikinase 97,659 6.31 XP_001705572 416
9 Alcohol dehydrogenase 97,134 6.31 XP_001710238 522
a Already published in Leitsch et al. (2011).






















Fig. 3. Non-protein thiol content in nitroimidazole-treated cells as compared to
untreated controls (100%). Mz, metronidazole; Tz, tinidazole; Rz, ronidazole; Az, 2-
nitroimidazole (azomycin). All nitroimidazoles were applied at a concentration of
50 lM for 2 h. All values were determined in at least three independent experi-
ments each. Error bars represent SEM.
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assays. Our previous results with T. vaginalis (Leitsch et al., 2009)
and E. histolytica (Leitsch et al., 2007) suggest that nitroimidazole
binding only inhibits some enzyme activities, e.g. thioredoxin
reductase, whereas other enzymes, e.g. thioredoxin peroxidase,
enolase and malate dehydrogenase in T. vaginalis, are not affected
(Leitsch et al., 2009).3.2. Nitroimidazoles decrease the intracellular thiol pools of G. lamblia
Since nitroimidazoles compromise the redox equilibrium in E.
histolytica (Leitsch et al., 2007) and T. vaginalis (Leitsch et al.,
2009) by strongly decreasing non-protein thiol levels, we wanted
to know whether nitroimidazole treatment leads to a similar effect
in G. lamblia. To this end, cultures of G. lamblia 106 were treated
with either 50 lM of metronidazole, tinidazole, ronidazole, or 2-
nitroimidazole for 2 h. Subsequently, reduced thiol pools were
determined with Ellman’s reagent (Leitsch et al., 2007, 2009) and
compared to untreated controls (Fig. 3). The non-protein thiol con-
tent of untreated G. lamblia 106 was 8.8 ± 3.7 nmol (mg protein)1.
All nitroimidazoles tested decreased non-protein thiol levels.
However, in stark contrast to E. histolytica (Leitsch et al., 2007)
and T. vaginalis (Leitsch et al., 2009), treatment with 2-nitroimidaz-
ole had the strongest effect, whereas metronidazole reduced thiol
levels by only 25% (Fig. 3).4. Conclusion
Taken together, our observations strongly suggest that nitroim-
idazoles are differently metabolized in G. lamblia as compared to
the other two parasites. Of the nitroimidazoles tested, only metro-
nidazole and tinidazole formed adducts with proteins (Fig. 2).
Treatment with ronidazole only induced the degradation of EF-
1c, and 2-nitroimidazole had no discernible effect on the 2D-pro-
ﬁle of treated G. lamblia at all. Further, nitroimidazoles affected
intracellular thiol pools in G. lamblia (Fig. 3) fundamentally differ-
ent as observed in E. histolytica and T. vaginalis (Leitsch et al., 2007,
2009). 2-Nitroimidazole depleted thiol levels in G. lamblia most
efﬁciently (Fig. 3), followed by ronidazole and tinidazole, whereas
metronidazole had only a modest effect. This is the exact opposite
of the situation in E. histolytica (Leitsch et al., 2007) and T. vaginalis
(Leitsch et al., 2009) where metronidazole is more effective than
tinidazole and 2-nitroimidazole.
It should be taken into consideration that G. lamblia dwells in
the small intestine and, therefore, is adapted to rather high concen-
trations of oxygen but low concentrations of reactive oxygen spe-
cies due to the presence of bile which contains high concentrations
of glutathione (Mastronicola et al., 2011). As compared to E. his-
tolytica and T. vaginalis, this could be reﬂected by a different set
of factors that inﬂuence metabolization of nitroimidazole drugs.
Further work will be necessary to identify these factors.Acknowledgements
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